R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, through its recent acquisition of VisitPay, today announced a collaboration with Memorial Sloan Kettering Cancer Center, the world’s oldest and largest private cancer center and one of 51 National Cancer Institute-Designated Cancer Centers, to implement a seamless and personalized digital financial experience for patients.
The VisitPay platform was developed to simplify patients’ overall financial experience and cost management by removing confusion and empowering payment autonomy among its users. The easy-to-use platform offers transparency into billing statements and cost consolidation across visits. With VisitPay, users can break down their medical bills into flexible payment plans.
As a result of the platform’s focus on patient empowerment, VisitPay’s Net Promoter Scores (NPS), a widely used measure of loyalty to a brand or service, are well above the healthcare industry average and on par with leading consumer brands.
“We are committed to supporting our patients in all aspects of their cancer care,” said Ankit Chhabra, MSK’s senior vice president of financial operations. “By introducing this patient-first digital engagement platform, we hope to make the financial aspect more seamless and manageable.”
“Our goal is to not only take the mystery, fear and frustration out of the payment experience, but also to empower the patient and allow them to focus their energy on healing and recovery,” said Kent Ivanoff, CEO of VisitPay, an R1 Company. “We are excited to collaborate with MSK to provide clear and consolidated billing that is easy to understand, frictionless to pay, and includes a compassionate approach. Together, we can help patients manage their medical obligations in a way that is helpful, at a time when they need it most.”